Abstract
Magnetic nanoparticles with tailored surface chemistry are widely used for a number of different in vivo applications, ranging from tissue repair and magnetic cell separation through to cancer-hyperthermia, drug delivery and magnetic resonance imaging contrast enhancement. A major requirement for all these biomedical applications is that these nanoparticles must have high magnetization values and sizes smaller than 100 nm with a narrow particle size distribution. Thus nanoparticles must have uniform physical and chemical properties. For these applications, a tailored surface coating/shell needs to be engineered, which has to be non-toxic, biocompatible and make allowance for targetable drug delivery with particle localization in a targeted area. Most work in this field has been done on improving the biocompatibility of the nanoparticles. Only a few scientific investigations have been carried out on improving the quality of magnetic nanoparticles with specific focus on the nanoparticle’s surface chemistry, size distribution and shape (which directly influences the magnetic properties). All these particles also need to be properly characterized in order to get a protocol for the quality control of these particles, the nature of the surface coatings and their subsequent geometric arrangement. This will ultimately determine the overall size of the colloids and also plays a significant role in biokinetics and biodistribution of nanoparticles in the body. This review highlights recent advances in the synthetic chemistry, magnetic characterization and biological applications of inorganic/organic - core/shell FexOy based magnetic nanoparticles with specific focus on using the two popular surfactants for producing MNPs namely oleic acid and/or oleylamine as capping agents. Although the main nano-magnets under discussion are magnetite (Fe3O4) nanoparticles, maghemite (γ-Fe2O3) is also briefly mentioned.
Keywords: Core/Shell, magnetic nanoparticles, oleic acid, oleylamine, magnetite, maghemite.
Current Pharmaceutical Design
Title:Engineered Inorganic/Organic-Core/Shell Magnetic FexOy Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents
Volume: 21 Issue: 37
Author(s): Richard Anthony Harris, Hendriëtte van der Walt and Poslet Morgan Shumbula
Affiliation:
Keywords: Core/Shell, magnetic nanoparticles, oleic acid, oleylamine, magnetite, maghemite.
Abstract: Magnetic nanoparticles with tailored surface chemistry are widely used for a number of different in vivo applications, ranging from tissue repair and magnetic cell separation through to cancer-hyperthermia, drug delivery and magnetic resonance imaging contrast enhancement. A major requirement for all these biomedical applications is that these nanoparticles must have high magnetization values and sizes smaller than 100 nm with a narrow particle size distribution. Thus nanoparticles must have uniform physical and chemical properties. For these applications, a tailored surface coating/shell needs to be engineered, which has to be non-toxic, biocompatible and make allowance for targetable drug delivery with particle localization in a targeted area. Most work in this field has been done on improving the biocompatibility of the nanoparticles. Only a few scientific investigations have been carried out on improving the quality of magnetic nanoparticles with specific focus on the nanoparticle’s surface chemistry, size distribution and shape (which directly influences the magnetic properties). All these particles also need to be properly characterized in order to get a protocol for the quality control of these particles, the nature of the surface coatings and their subsequent geometric arrangement. This will ultimately determine the overall size of the colloids and also plays a significant role in biokinetics and biodistribution of nanoparticles in the body. This review highlights recent advances in the synthetic chemistry, magnetic characterization and biological applications of inorganic/organic - core/shell FexOy based magnetic nanoparticles with specific focus on using the two popular surfactants for producing MNPs namely oleic acid and/or oleylamine as capping agents. Although the main nano-magnets under discussion are magnetite (Fe3O4) nanoparticles, maghemite (γ-Fe2O3) is also briefly mentioned.
Export Options
About this article
Cite this article as:
Harris Anthony Richard, van der Walt Hendriëtte and Shumbula Morgan Poslet, Engineered Inorganic/Organic-Core/Shell Magnetic FexOy Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents, Current Pharmaceutical Design 2015; 21 (37) . https://dx.doi.org/10.2174/1381612821666150917092826
DOI https://dx.doi.org/10.2174/1381612821666150917092826 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Current Medicinal Chemistry Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Applied Pathology for Interventions of Coronary Chronic Total Occlusion
Current Cardiology Reviews Recreational Drug Misuse and Stroke
Current Drug Abuse Reviews Cardiovascular-Related
Current Bioactive Compounds Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
Current Cardiology Reviews Chilling-Like Attacks Terminated by Slow Pathway Ablation
Current Cardiology Reviews Phytochemical and Pharmacological Insight on Sesamol: An Updated Review
Current Bioactive Compounds Attenuation of Hydroxyl Radical Formation by Extracted Constituent of Moringa oleifera Lam
Current Chemical Biology Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
Current Vascular Pharmacology Snake Venom Prothrombin Activators Similar to Blood Coagulation Factor Xa
Current Drug Targets - Cardiovascular & Hematological Disorders Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment of Pulmonary Embolism
Current Pharmaceutical Design Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Current Molecular Pharmacology Scleroderma Renal Crisis Accompanied by New-Onset Pulmonary Hypertension: An Acute Systemic Endothelial Injury? Case Report and Literature Review
Inflammation & Allergy - Drug Targets (Discontinued) UPLC-DAD Assisted Phytochemical Quantitation Reveals a Sex, Ploidy and Ecogeography Specificity in the Expression Levels of Selected Secondary Metabolites in Medicinal Tinospora cordifolia: Implications for Elites’ Identification Program
Current Topics in Medicinal Chemistry Management of Acute Aluminum Phosphide Poisoning: Has Anything Changed?
Drug Metabolism Letters Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging